mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.4 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.042 |
0.4 |